Skip to main content
Oncotarget logoLink to Oncotarget
. 2023 Jul 20;14:721. doi: 10.18632/oncotarget.28478

Addendum: Systemic AL amyloidosis: current approach and future direction

Maroun Bou Zerdan 1, Lewis Nasr 2, Farhan Khalid 3, Sabine Allam 4, Youssef Bouferraa 5, Saba Batool 6, Muhammad Tayyeb 7, Shubham Adroja 8, Mahinbanu Mammadii 1, Faiz Anwer 9, Shahzad Raza 9, Chakra P Chaulagain 10,
PMCID: PMC10360921  PMID: 37477528

This article has an addendum: Research funding was obtained from the Cleveland Clinic Florida, Maroone Cancer Center, Malignant Hematology Research Fund.

Original article: Oncotarget. 2023; 14:384–394. 384-394. https://doi.org/10.18632/oncotarget.28415


Articles from Oncotarget are provided here courtesy of Impact Journals, LLC

RESOURCES